Both in Pharmaceuticals
NextCure vs ABVC BioPharma
Over the past year NXTC returned −48.5% and ABVC returned −64.5%; their daily moves had a correlation of 0.03.
NXTC −48.5% ABVC −64.5%Growth of $1, one year, split-adjusted
| Metric | NXTC | ABVC |
|---|---|---|
| Price | $6.31 | $1.00 |
| Market cap | $28.9M | $26.7M |
| Today | −3.29% | −3.85% |
| 1 month | +27.2% | −2.0% |
| 6 months | −32.6% | −2.9% |
| Year to date | −55.5% | −53.1% |
| 1 year | −47.3% | −63.9% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $20.1M | $34.9K |
| Dividend yield | — | — |
| Volatility (60d) | 113.8% | 79.2% |
| Short % of float | 8.4% | 2.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).